Publication | Open Access

Presence and type of low density lipoprotein receptor (LDLR) mutation influences the lipid profile and response to lipid-lowering therapy in Brazilian patients with heterozygous familial hypercholesterolemia

Metabolic SyndromeLipid DisorderCardiovascular DiseaseGlobal HealthGenetic EpidemiologyLipid-lowering TherapyHyperlipidemiaDyslipidemiaLipoprotein MetabolismPublic HealthLipid ProfileAtherosclerosisEpidemiologyBrazilian Patients